1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine hydrochloride
| Title | Journal |
|---|---|
| Sibutramine provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species. | Toxicology and applied pharmacology 20170101 |
| Effects of oral anorexiant sibutramine on the expression of cytochromes P450s in human hepatocytes and cancer cell lines. | Journal of biochemical and molecular toxicology 20131201 |
| Short-term effects of sibutramine on mineral status and selected biochemical parameters in obese women. | Biological trace element research 20121101 |
| Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine. | Diabetes, obesity & metabolism 20121101 |
| Evaluation of mutagenic effect of two antiobesity drugs on mice's genetic materials. | Drug and chemical toxicology 20121001 |
| Calorimetric, FTIR and 1H NMR measurements in combination with DFT calculations for monitoring solid-state changes of dynamics of sibutramine hydrochloride. | Journal of pharmaceutical sciences 20121001 |
| Partial conversion of methanol to formaldehyde in the gas chromatography injection port and reactivity with amines. | Journal of chromatography. A 20120928 |
| Changes of cytosolic calcium and contractility of young rat vas deferens by acute treatment with amphetamine, fluoxetine or sibutramine. | European journal of pharmacology 20120915 |
| Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome. | European journal of obstetrics, gynecology, and reproductive biology 20120801 |
| Rapid screening of illicit additives in weight loss dietary supplements with desorption corona beam ionisation (DCBI) mass spectrometry. | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20120801 |
| Safety assessment of an anti-obesity drug (sibutramine): a retrospective cohort study. | Drug safety 20120801 |
| Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. | Diabetes, obesity & metabolism 20120601 |
| Sibutramine promotes amygdala activity under fasting conditions in obese women. | Psychopharmacology 20120601 |
| A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20120601 |
| Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention. | Clinical pharmacology and therapeutics 20120601 |
| Effect of sibutramine on 5-hydroxyindole acetic acid levels and selected oxidative biomarkers on brain regions of female rats in the presence of zinc. | Basic & clinical pharmacology & toxicology 20120501 |
| Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008. | Annals of epidemiology 20120501 |
| Comparative determination of sibutramine as an adulterant in natural slimming products by HPLC and HPTLC densitometry. | Journal of pharmaceutical and biomedical analysis 20120501 |
| Food and Drug Administration's Obesity Drug Guidance Document: a short history. | Circulation 20120501 |
| Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. | Obesity surgery 20120401 |
| Serotonin syndrome following overdose of a non-prescription slimming product containing sibutramine: a case report. | Human & experimental toxicology 20120401 |
| Olanzapine and sibutramine have opposing effects on the motivation for palatable food. | Behavioural pharmacology 20120401 |
| The perils of pharmacological treatment for obesity: a case of sibutramine-associated cardiomyopathy and malignant arrhythmias. | Cardiovascular journal of Africa 20120312 |
| [The pharmacological treatment of obesity: past, present and future]. | Orvosi hetilap 20120311 |
| What cost weight loss? | Circulation 20120306 |
| Multidisciplinary intervention with sibutramine: assessing successful weight loss predictors in military adolescent dependents. | Military medicine 20120301 |
| Chiral discrimination of sibutramine enantiomers by capillary electrophoresis and proton nuclear magnetic resonance spectroscopy. | Archives of pharmacal research 20120301 |
| Serotonin receptor 2A -1438G/A promoter polymorphism in relation to obesity and response to sibutramine. | Genetic testing and molecular biomarkers 20120201 |
| Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats. | Acta pharmacologica Sinica 20120201 |
| Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20120101 |
| Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States. | Journal of general internal medicine 20120101 |
| Sibutramine for the treatment of recurrent high-flow priapism. | Journal of andrology 20120101 |
| What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. | Health technology assessment (Winchester, England) 20120101 |
| Desipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells. | PloS one 20120101 |
| Sibutramine-induced mania as the first manifestation of bipolar disorder. | BMC psychiatry 20120101 |
| A GC-EI-MS-MS method for simultaneous determination of seven adulterants in slimming functional foods. | Journal of chromatographic science 20120101 |
| Experimental study of the effects of Dietressa, a new weight-reducing drug. | Bulletin of experimental biology and medicine 20120101 |
| A new approach to determining pharmacologic adulteration of herbal weight loss products. | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20120101 |
| X-ray powder diffractometry and liquid chromatography studies of sibutramine and its analogues content in herbal dietary supplements. | Journal of pharmaceutical and biomedical analysis 20111215 |
| Effects of clopidogrel on the pharmacokinetics of sibutramine and its active metabolites. | Journal of clinical pharmacology 20111201 |
| Long-term health benefits of appetite suppressants remain unproven. | Revista de saude publica 20111201 |
| Determination of tadalafil and N-desmethylsibutramine in health and dietary supplements using ultra-performance liquid chromatography (UPLC) coupled with quadrupole-time-of-flight mass spectrometry (Q-TOF MS). | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20111101 |
| Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals. | Diabetes research and clinical practice 20111101 |
| Development of a liquid chromatography tandem mass spectrometry method for simultaneous determination of eight adulterants in slimming functional foods. | Journal of chromatography. A 20111021 |
| Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients. | Journal of clinical pharmacy and therapeutics 20111001 |
| Inverse agonism at α2A adrenoceptors augments the hypophagic effect of sibutramine in rats. | Obesity (Silver Spring, Md.) 20111001 |
| Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find? | Current opinion in endocrinology, diabetes, and obesity 20111001 |
| Topiramate induces weight loss and improves insulin sensitivity in dietary obese rats: comparison to sibutramine. | European review for medical and pharmacological sciences 20111001 |
| Drug treatment for obesity in the post-sibutramine era. | Drug safety 20110801 |
| [Pharmacological concepts for the treatment of obesity - a therapeutic meander?]. | Deutsche medizinische Wochenschrift (1946) 20110801 |
| [Simultaneous determination of 15 anti-obesity drugs in blood by high performance liquid chromatography-tandem mass spectrometry]. | Se pu = Chinese journal of chromatography 20110801 |
| Sibutramine: balanced judgment or prejudice? | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20110601 |
| No compelling evidence that sibutramine prolongs life in rodents despite providing a dose-dependent reduction in body weight. | International journal of obesity (2005) 20110501 |
| Sibutramine on cardiovascular outcome. | Diabetes care 20110501 |
| Comparative efficiency and safety of pharmacological approaches to the management of obesity. | Diabetes care 20110501 |
| Reverse migration order of sibutramine enantiomers as a function of cyclodextrin concentration in capillary electrophoresis. | Journal of pharmaceutical and biomedical analysis 20110405 |
| Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist. | Psychopharmacology 20110401 |
| Proteome changes in rat plasma in response to sibutramine. | Proteomics 20110401 |
| Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. | Metabolism: clinical and experimental 20110301 |
| Changes of body weight and inflammatory markers after 12-week intervention trial: results of a double-blind, placebo-control pilot study. | Yonsei medical journal 20110301 |
| Pharmacological treatment of obesity: a public health perspective. | Cadernos de saude publica 20110301 |
| [Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review]. | Ugeskrift for laeger 20110221 |
| Using a portable ion mobility spectrometer to screen dietary supplements for sibutramine. | Journal of pharmaceutical and biomedical analysis 20110220 |
| The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet. | Journal of pharmaceutical and biomedical analysis 20110105 |
| Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects. | Journal of clinical pharmacology 20110101 |
| The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. | Endocrine journal 20110101 |
| [Moxibustion on the Governor Vessel for lung and kidney qi deficiency type in chronic obstructive pulmonary disease: a randomized controlled trial]. | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20110101 |
| Hepatic PTP1B expression involvement in the effects of Chinese medicine formula xiao-gao-jiang-zhuo using an obese rat model. | The American journal of Chinese medicine 20110101 |
| Impact of waist circumference reduction on cardiovascular risk in treated obese subjects. | Cirugia y cirujanos 20110101 |
| Acceleration of sperm transit time and reduction of sperm reserves in the epididymis of rats exposed to sibutramine. | Journal of andrology 20110101 |
| [Sibutramine and its adequate usage]. | Nihon rinsho. Japanese journal of clinical medicine 20110101 |
| Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents. | Nutricion hospitalaria 20110101 |
| Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks. | Obesity facts 20110101 |
| [Adverse drug reactions of a slimming product contaminated with sibutramine]. | Nederlands tijdschrift voor geneeskunde 20110101 |
| Cost-effectiveness of pharmacotherapy to reduce obesity. | PloS one 20110101 |
| A case of sibutramine-induced hyperprolactinemia. | Neuro endocrinology letters 20110101 |
| Study on detection of drugs in slimming health foods using GC-MS/MS. | Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan 20110101 |
| [The obesity and way for treatment]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20110101 |
| Simultaneous thin-layer chromatography-densitometric analysis of sibutramine and citalopram. | Folia medica 20110101 |
| Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20101101 |
| Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats. | Pharmacology, biochemistry, and behavior 20101101 |
| Elevation of QT dispersion after obesity drug sibutramine. | Journal of cardiovascular medicine (Hagerstown, Md.) 20101101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Sibutramine (Meridia) withdrawn. | The Medical letter on drugs and therapeutics 20101101 |
| Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20101027 |
| Contrasting effects of systemic and central sibutramine administration on the intake of a palatable diet in the rat. | Neuroscience letters 20101022 |
| European Medicines Agency withdrawal for sibutramine. | Archives of disease in childhood 20101001 |
| Hypothalamic orexin and pro-opiomelanocortin activities are essential for the anorexic effects of m-chlorophenylpiperazine in mice. | The international journal of neuropsychopharmacology 20101001 |
| Recurrent episodes of brief affective psychosis induced by sibutramine. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series. | Clinical toxicology (Philadelphia, Pa.) 20101001 |
| [Classified teaching of acupoints: standardized teaching in Jingluo Shuxue Xue (Channels and Acupoints science)]. | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20101001 |
| [Suspension of the commercialization of sibutramine and rosiglitazone in Europe]. | Revue medicale de Liege 20101001 |
| Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. | International journal of pharmaceutics 20100915 |
| Weight loss maintenance. | American family physician 20100915 |
| Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. | The New England journal of medicine 20100902 |
| Sibutramine--another flawed diet pill. | The New England journal of medicine 20100902 |
| Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women. | Clinical and experimental medicine 20100901 |
| Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. | Obesity (Silver Spring, Md.) 20100901 |
| Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. | The Journal of endocrinology 20100901 |
| Fat attack. | Scientific American 20100901 |
| [The trial that killed a drug]. | Lakartidningen 20100901 |
| [Withdrawal of sibutramine for cardiovascular disease risk]. | Revista peruana de medicina experimental y salud publica 20100901 |
| [Simultaneous determination of five illegal drugs in weight control foods with solid phase extraction-high performance liquid chromatography]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20100901 |
| Assessment of the application of the intragastric balloon together with sibutramine: a prospective clinical study. | Obesity surgery 20100801 |
| Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20100801 |
| Myocardial infarction associated with sibutramine use: case report and discussion. | Military medicine 20100801 |
| Drug management of obesity--efficacy versus safety. | The New England journal of medicine 20100715 |
| Analysis of adulterated herbal medicines and dietary supplements marketed for weight loss by DOSY 1H-NMR. | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20100701 |
| Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort study. | Drug safety 20100701 |
| Controversy about the cardiovascular safety of sibutramine. | Drug safety 20100701 |
| The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant. | European journal of pharmacology 20100625 |
| Office-based strategies for the management of obesity. | American family physician 20100615 |
| Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20100601 |
| Withdrawal of sibutramine for weight loss: where does this leave clinicians? | Obesity facts 20100601 |
| Absence of sibutramine effect on spontaneous anxiety in rats. | Arquivos brasileiros de endocrinologia e metabologia 20100601 |
| Sibutramine: cardiovascular events. | Prescrire international 20100601 |
| Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in period. | Obesity (Silver Spring, Md.) 20100501 |
| [32-year-old patient with acute myocardial infarction possibly induced by the appetite suppressant sibutramine]. | Deutsche medizinische Wochenschrift (1946) 20100501 |
| Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20100401 |
| Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population. | Molecular diagnosis & therapy 20100401 |
| Withdrawal of sibutramine. Editorial is judgment in advance of the facts. | BMJ (Clinical research ed.) 20100310 |
| Withdrawal of sibutramine. Magic bullets now uncontrolled. | BMJ (Clinical research ed.) 20100310 |
| Use of psychotropic drugs and analgesics among users of antiobesity drugs--a population based study. | Pharmacoepidemiology and drug safety 20100301 |
| An evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex. | Human & experimental toxicology 20100301 |
| Pharmacologic therapies for obesity. | Gastroenterology clinics of North America 20100301 |
| Transient global amnesia after taking sibutramine: a case report. | The neurologist 20100301 |
| An obesity drug sibutramine reduces brain natriuretic peptide (BNP) levels in severely obese patients. | International journal of clinical practice 20100301 |
| Sibutramine & naloxone: infra-additive interaction in the regulation of appetite? | Behavioural brain research 20100211 |
| Withdrawal of sibutramine in Europe. | BMJ (Clinical research ed.) 20100209 |
| Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20100201 |
| Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100201 |
| Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF. | Pediatrics 20100201 |
| Acute coronary syndrome in a young woman treated with sibutramine. | Revista espanola de cardiologia 20100201 |
| Enantioselective pharmacokinetics of sibutramine in rat. | Archives of pharmacal research 20100201 |
| [Clinical observation on therapeutic effect of electric-heat needle combined with acupoint sticking therapy for treatment of simple obesity]. | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20100201 |
| [Back at the starting point. Obesity patients the losers when sibutramine (Reductil) is recalled]. | Lakartidningen 20100201 |
| Withdrawal of sibutramine leaves European doctors with just one obesity drug. | BMJ (Clinical research ed.) 20100125 |
| [Questions surrounding sibutramine for obesity]. | Revue medicale suisse 20100113 |
| Enantioselective determination of sibutramine and its active metabolites in human plasma. | Journal of pharmaceutical and biomedical analysis 20100105 |
| The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women. | Journal of psychopharmacology (Oxford, England) 20100101 |
| Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. | Diabetes, obesity & metabolism 20100101 |
| Sibutramine selective electrodes for batch and flow injection determinations in pharmaceutical preparations. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101 |
| Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium. | Biological & pharmaceutical bulletin 20100101 |
| Various emetogens increase the secretion of salivary amylase in rats: a potential model in emesis research. | Journal of pharmacological sciences 20100101 |
| Sibutramine effects on the reproductive performance of pregnant overweight and non-overweight rats. | Journal of toxicology and environmental health. Part A 20100101 |
| Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. | Internal medicine (Tokyo, Japan) 20100101 |
| Cardiovascular risk-benefit profile of sibutramine. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101 |
| [Effect of sibutramine (meridia) on body composition, peptide YY3-36 and serotonin levels in patients with exogenous constitutional obesity]. | Terapevticheskii arkhiv 20100101 |
| Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101 |
| [First-episode mania with psychotic features induced by over-the-counter diet aids containing sibutramine]. | Turk psikiyatri dergisi = Turkish journal of psychiatry 20100101 |
| Highly enantioselective catalytic asymmetric synthesis of a (R)-sibutramin precursor. | Chimia 20100101 |
| [Medicinal drug resemble ingredients in health foods]. | Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan 20100101 |
| [About the withdrawal of sibutramine in Peru]. | Revista peruana de medicina experimental y salud publica 20100101 |
| Simultaneous determination of anti-diabetes/anti-obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplements by LC/MS/MS. | Biomedical chromatography : BMC 20091201 |
| Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. | Clinical pharmacology and therapeutics 20091201 |
| Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20091201 |
| Practical methods for improving flow properties of active pharmaceutical ingredients. | Drug development and industrial pharmacy 20091201 |
| Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study. | British journal of clinical pharmacology 20091201 |
| Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects. | Clinical pharmacology and therapeutics 20091101 |
| Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time. | Obesity surgery 20091101 |
| Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats. | Canadian journal of physiology and pharmacology 20091101 |
| Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20091015 |
| Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use. | International journal of cardiology 20091002 |
| Analysis of sibutramine metabolites as N-trifluoroacetamide and O-trimethylsilyl derivatives by gas chromatography-mass spectrometry in urine. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001 |
| What are the risks and the benefits of current and emerging weight-loss medications? | Current diabetes reports 20091001 |
| Comparative bioavailability of two formulations of sibutramine. | International journal of clinical pharmacology and therapeutics 20091001 |
| Multiple effects of sibutramine on ejaculation and on vas deferens and seminal vesicle contractility. | Toxicology and applied pharmacology 20090915 |
| Analysis of enantiomers of sibutramine and its metabolites in rat plasma by liquid chromatography-mass spectrometry using a chiral stationary-phase column. | Journal of pharmaceutical and biomedical analysis 20090908 |
| Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. | The European respiratory journal 20090901 |
| Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats. | Addiction biology 20090901 |
| Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20090901 |
| Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. | Pharmacogenetics and genomics 20090901 |
| Pharmacotherapy in pediatric obesity: current agents and future directions. | Reviews in endocrine & metabolic disorders 20090901 |
| A retrospective review of California poison control system data of sibutramine exposures. | Clinical toxicology (Philadelphia, Pa.) 20090901 |
| Crude herbal drugs may be safe. | Deutsches Arzteblatt international 20090901 |
| Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. | Metabolism: clinical and experimental 20090801 |
| Predictors of attrition and weight loss success: Results from a randomized controlled trial. | Behaviour research and therapy 20090801 |
| Long-term effects of weight-reducing drugs in hypertensive patients. | The Cochrane database of systematic reviews 20090708 |
| Effect of antiobesity medications in patients with type 2 diabetes mellitus. | Diabetes, obesity & metabolism 20090701 |
| Sibutramine-induced recurrent seizures. | Epilepsy & behavior : E&B 20090701 |
| Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasma. | Clinical toxicology (Philadelphia, Pa.) 20090701 |
| Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome. | Fertility and sterility 20090601 |
| [Pharmaceutical treatment of binge eating disorder]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20090601 |
| A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam. | Psychopharmacology 20090501 |
| Effect of sibutramine on Na+, K+ ATPase activity and tryptophan levels on male and female rat brain. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20090501 |
| Changes in symptoms of depression with weight loss: results of a randomized trial. | Obesity (Silver Spring, Md.) 20090501 |
| Serum adiponectin and resistin in rats under three isocaloric diets: The effect of sibutramine. | Cytokine 20090501 |
| Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation. | Psychopharmacology 20090401 |
| Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice. | Journal of ethnopharmacology 20090318 |
| Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats. | Behavioural brain research 20090317 |
| Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT). | Diabetes, obesity & metabolism 20090301 |
| 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats. | Obesity (Silver Spring, Md.) 20090301 |
| The anorexic agents, sibutramine and fenfluramine, depress GABA(B)-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells. | British journal of pharmacology 20090301 |
| The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. | Arquivos brasileiros de endocrinologia e metabologia 20090301 |
| Chinese slimming capsules containing sibutramine sold over the Internet: a case series. | Deutsches Arzteblatt international 20090301 |
| Bonghan system as mesenchymal stem cell niches and pathways of macrophages in adipose tissues. | Journal of acupuncture and meridian studies 20090301 |
| Demo-experiments of Bonghan ducts in Beijing. | Journal of acupuncture and meridian studies 20090301 |
| Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. | Annals of internal medicine 20090217 |
| Characterization of metabolites of sibutramine in primary cultures of rat hepatocytes by liquid chromatography-ion trap mass spectrometry. | Analytical and bioanalytical chemistry 20090201 |
| Current pharmacotherapeutic concepts for the treatment of obesity in adults. | Therapeutic advances in cardiovascular disease 20090201 |
| Effect of sibutramine HCl on cardiac hERG K+ channel. | Molecular and cellular biochemistry 20090101 |
| Pharmacotherapy for eating disorders and obesity. | Child and adolescent psychiatric clinics of North America 20090101 |
| Recent advances in obesity pharmacotherapy. | Current clinical pharmacology 20090101 |
| Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine. | Internal medicine (Tokyo, Japan) 20090101 |
| Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis. | BMC psychiatry 20090101 |
| Development and validation of a column high-performance liquid chromatographic method for determination of sibutramine in capsules. | Journal of AOAC International 20090101 |
| The use of sibutramine in the management of obesity and related disorders: an update. | Vascular health and risk management 20090101 |
| [Drug treatment of obesity]. | Revue medicale de Bruxelles 20090101 |
| Pharmacotherapy and surgery treatment for the severely obese adolescent. | Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 20090101 |
| Sibutramine--its impact on health-related quality of life and depression among adult obese non-diabetic patients. | Bratislavske lekarske listy 20090101 |
| What extent of weight loss can benefit the health-related quality of life in motivated obese Chinese? | Asia Pacific journal of clinical nutrition 20090101 |
| Comparison of rimonabant and sibutramine treatment effects on food compulsion in rats. | Acta cirurgica brasileira 20090101 |
| [Sibutramine-related panic attack: a clinical case of apparent resolution with paroxetine]. | Rivista di psichiatria 20090101 |
| Influence of sibutramine, orlistat and Ispaghula in reducing body weight and total body fat content in obese individuals. | Journal of Ayub Medical College, Abbottabad : JAMC 20090101 |
| Crystal chemistry of sibutramine: thermal, diffractometric and spectroscopic characterization. | Journal of pharmaceutical sciences 20081201 |
| Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review. | International journal of obesity (2005) 20081201 |
| A possible mechanism for severe symptomatic hyponatremia during sibutramine therapy. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20081201 |
| Hypomanic episode secondary to sibutramine in a patient with type-I bipolar disorder. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20081201 |
| Sibutramine-induced acute myocardial infarction in a young lady. | Clinical toxicology (Philadelphia, Pa.) 20081101 |
| Sibutramine-induced psychotic episode in an adolescent. | Journal of psychosomatic research 20081101 |
| Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone. | Metabolism: clinical and experimental 20081101 |
| Implementing antiobesity treatment in a patient with a mood disorder. | Journal of psychiatry & neuroscience : JPN 20081101 |
| Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial. | Journal of cardiovascular pharmacology 20081101 |
| Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis. | Sao Paulo medical journal = Revista paulista de medicina 20081101 |
| Request for slimming tablets. | BMJ (Clinical research ed.) 20081024 |
| Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. | Endocrine journal 20081001 |
| The effect of sibutramine therapy on occurrence of depression symptoms among obese patients. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20081001 |
| A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. | Gastroenterology 20081001 |
| Sibutramine-associated QT interval prolongation and cardiac arrest. | The Annals of pharmacotherapy 20081001 |
| [Association of obesity and depression]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20081001 |
| Head-to-head studies evaluating efficacy of pharmaco-therapy for obesity: a systematic review and meta-analysis. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20080901 |
| Effect of sibutramine on regional fat pads and leptin levels in rats fed with three isocaloric diets. | European cytokine network 20080901 |
| Simultaneous determination of sibutramine and N-Di-desmethylsibutramine in dietary supplements for weight control by HPLC-ESI-MS. | Journal of chromatographic science 20080901 |
| [Obesity and oral health: risk factors of obese patients in dental practice]. | Odonto-stomatologie tropicale = Tropical dental journal 20080901 |
| Effectiveness of weight management programs in children and adolescents. | Evidence report/technology assessment 20080901 |
| Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. | Drug metabolism and disposition: the biological fate of chemicals 20080801 |
| Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. | International journal of obesity (2005) 20080801 |
| Determination of the active metabolites of sibutramine in rat serum using column-switching HPLC. | Journal of separation science 20080801 |
| Sibutramine: current status as an anti-obesity drug and its future perspectives. | Expert opinion on pharmacotherapy 20080801 |
| Sibutramine-associated adverse effects: a practical guide for its safe use. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20080701 |
| Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine. | Obesity (Silver Spring, Md.) 20080701 |
| Severe symptomatic hyponatremia during sibutramine therapy: a case report. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20080701 |
| Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients. | Expert opinion on pharmacotherapy 20080701 |
| Concerns about the safety of obesity agents from a manufacturing perspective. | Postgraduate medicine 20080701 |
| Label-inconsistent use of sibutramine in spontaneous adverse drug reaction reports in Germany. | International journal of clinical pharmacology and therapeutics 20080701 |
| Electrophysiological safety of sibutramine HCl. | Human & experimental toxicology 20080701 |
| Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. | Diabetes, obesity & metabolism 20080601 |
| Orlistat and sibutramine beyond weight loss. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20080601 |
| Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox. | Journal of human nutrition and dietetics : the official journal of the British Dietetic Association 20080601 |
| Sibutramine: balancing weight loss benefit and possible cardiovascular risk. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20080601 |
| Pharmacotherapy for obesity in menopausal women. | Menopause international 20080601 |
| Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study. | Psychiatry research 20080530 |
| Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. | Fertility and sterility 20080501 |
| Peripheral endocannabinoid system activity in patients treated with sibutramine. | Obesity (Silver Spring, Md.) 20080501 |
| [Sibutramine associated psychotic episode: a case report]. | Revista medica de Chile 20080501 |
| Sibutramine-associated psychosis (case report). | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20080501 |
| Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study. | International journal of obesity (2005) 20080401 |
| Sympathetic-leptin relationship in obesity: effect of weight loss. | Metabolism: clinical and experimental 20080401 |
| Development and validation of high performance liquid chromatography method for analysis of sibutramine hydrochloride and its impurity. | Pakistan journal of pharmaceutical sciences 20080401 |
| [Pharmacological therapy of obesity]. | Giornale italiano di cardiologia (2006) 20080401 |
| Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. | Archives of internal medicine 20080324 |
| Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20080301 |
| Another dangerous combination for hypoglycemic coma: concurrent use of sibutramine and lorazepam. | QJM : monthly journal of the Association of Physicians 20080301 |
| Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat. | Molecular psychiatry 20080301 |
| A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation. | Pharmacogenetics and genomics 20080201 |
| Effects of sibutramine on gastric emptying, intestinal motility and rectal tone in dogs. | Digestive diseases and sciences 20080101 |
| Psychopathology in the context of obesity: the adiponectin hypothesis. | Medical hypotheses 20080101 |
| The development of tolerance to drugs that suppress food intake. | Pharmacology & therapeutics 20080101 |
| Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. | The American journal of psychiatry 20080101 |
| [Pharmacotherapy of obesity]. | Der Internist 20080101 |
| Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. | Journal of psychosomatic research 20080101 |
| Binge eating disorder: the search for better treatments. | The American journal of psychiatry 20080101 |
| Successful treatment of a morbidly obese and growth-retarded adolescent with Williams-Beuren Syndrome by combining the medication of growth hormone and sibutramine. | Singapore medical journal 20080101 |
| Obesity: a review of pathogenesis and management strategies. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20080101 |
| Emerging concepts in the medical and surgical treatment of obesity. | Frontiers of hormone research 20080101 |
| The effect of sibutramine intake on resting and exercise physiological responses. | Annals of nutrition & metabolism 20080101 |
| [Study on the interaction of serum albumin and micromolecule compounds by modified fluorescence spectra]. | Guang pu xue yu guang pu fen xi = Guang pu 20080101 |
| Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats. | Pharmacology 20080101 |
| Development and validation of sensitive methods for determination of sibutramine hydrochloride monohydrate and direct enantiomeric separation on a protein-based chiral stationary phase. | Journal of AOAC International 20080101 |
| Fundamentals of cardiometabolic risk factor reduction: achieving and maintaining weight loss with pharmacotherapy or bariatric surgery. | Clinical cornerstone 20080101 |
| The endocannabinoid system as a target for obesity treatment. | Clinical cornerstone 20080101 |
| Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. | European heart journal 20071201 |
| Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon? | European heart journal 20071201 |
| Sibutramine and psychosis. | Journal of clinical psychopharmacology 20071201 |
| Pharmacotherapy for obesity. | Current atherosclerosis reports 20071201 |
| [Effect of weight loss on blood pressure]. | MMW Fortschritte der Medizin 20071129 |
| [Antiobesity drugs--new limitations]. | Revue medicale suisse 20071128 |
| Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme. | Pharmacoepidemiology and drug safety 20071101 |
| Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. | The Journal of clinical endocrinology and metabolism 20071101 |
| The obese older female patient: CV risk and the SCOUT study. | International journal of obesity (2005) 20071101 |
| Myocardial infarction induced by appetite suppressants in Malaysia. | The New England journal of medicine 20071101 |
| The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England. | Obesity (Silver Spring, Md.) 20071101 |
| [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development]. | Postepy higieny i medycyny doswiadczalnej (Online) 20071019 |
| [Obesity in adults]. | Praxis 20071017 |
| Long-term persistence with orlistat and sibutramine in a population-based cohort. | International journal of obesity (2005) 20071001 |
| Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. | Public health nutrition 20071001 |
| Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. | Journal of the American Dietetic Association 20071001 |
| Cardiovascular effects of sibutramine. | Pediatrics 20071001 |
| Strategies to reduce vascular risk associated with obesity. | Current vascular pharmacology 20071001 |
| Impact of weight loss on the metabolic syndrome. | International journal of obesity (2005) 20070901 |
| The obesity pandemic--how did we get here? | The Annals of pharmacotherapy 20070901 |
| Pharmacotherapeutic options for overweight adolescents. | The Annals of pharmacotherapy 20070901 |
| [Pharmacotherapy for weight loss in patients with type 2 diabetes]. | Ugeskrift for laeger 20070813 |
| Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20070801 |
| NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. | Obesity (Silver Spring, Md.) 20070801 |
| Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070701 |
| Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. | Pediatrics 20070701 |
| The cost-effectiveness of sibutramine in non-diabetic obese patients: evidence from four Western countries. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20070701 |
| National trends in the use and costs of anti-obesity medications in England 1998-2005. | Journal of public health (Oxford, England) 20070601 |
| Psychosis with sibutramine. | Journal of clinical psychopharmacology 20070601 |
| A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. | Bipolar disorders 20070601 |
| Adulteration of over-the-counter slimming products with pharmaceutical analogue--an emerging threat. | Hong Kong medical journal = Xianggang yi xue za zhi 20070601 |
| Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients. | Obesity (Silver Spring, Md.) 20070601 |
| Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine. | The Journal of pharmacology and experimental therapeutics 20070501 |
| Drug treatment of the overweight patient. | Gastroenterology 20070501 |
| Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. | Circulation 20070417 |
| The obese hypertensive: the weight of evidence against beta-blockers. | Circulation 20070417 |
| [New therapeutic aspects for the control of risk factors in obesity]. | Medicina clinica 20070407 |
| Placebo response in binge eating disorder. | The International journal of eating disorders 20070401 |
| The effect of sibutramine on energy expenditure and body composition in obese adolescents. | The Journal of clinical endocrinology and metabolism 20070401 |
| Sympathetic vasomotor tone determines blood pressure response to long-term sibutramine treatment. | The Journal of clinical endocrinology and metabolism 20070401 |
| Therapeutic options for modifying cardiometabolic risk factors. | The American journal of medicine 20070301 |
| Acute effects of sibutramine administration on the autonomic nervous system in obese subjects. | Clinical pharmacology and therapeutics 20070301 |
| [Childhood obesity. Recommendations of the Nutrition Committee of the Spanish Association of Pediatrics. Part II. Diagnosis. Comorbidities. Treatment]. | Anales de pediatria (Barcelona, Spain : 2003) 20070301 |
| Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. | The American journal of cardiology 20070219 |
| Incorrect use of orlistat and sibutramine in clinical practice. | European journal of clinical pharmacology 20070201 |
| A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. | Acta psychiatrica Scandinavica 20070201 |
| Rapid and sensitive method for the determination of sibutramine active metabolites in human plasma by reversed-phase liquid chromatography-tandem mass spectroscopy. | Journal of chromatographic science 20070201 |
| Exposure to sibutramine during pregnancy. | Canadian family physician Medecin de famille canadien 20070201 |
| Drug treatments for obesity: orlistat, sibutramine, and rimonabant. | Lancet (London, England) 20070106 |
| The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. | International journal of obesity (2005) 20070101 |
| The obesity epidemic: current and future pharmacological treatments. | Annual review of pharmacology and toxicology 20070101 |
| Phentermine, sibutramine and metformin could be used for the prevention and treatment of steroid-induced weight gain. | Medical hypotheses 20070101 |
| Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites. | Rapid communications in mass spectrometry : RCM 20070101 |
| Detection of sibutramine, its two metabolites and one analogue in a herbal product for weight loss by liquid chromatography triple quadrupole mass spectrometry and time-of-flight mass spectrometry. | Rapid communications in mass spectrometry : RCM 20070101 |
| Currently available drugs for the treatment of obesity: Sibutramine and orlistat. | Mini reviews in medicinal chemistry 20070101 |
| A sibutramine-induced delusional disorder relapse. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study. | Annals of nutrition & metabolism 20070101 |
| [Patients with type III obesity given sibutramine 15 mg/day lose weight in amounts proportional to those in types I and II, but waist circumferences does not decrease proportionally]. | Gaceta medica de Mexico 20070101 |
| Weight loss in obese African American and Caucasian adolescents: secondary analysis of a randomized clinical trial of behavioral therapy plus sibutramine. | The Journal of cardiovascular nursing 20070101 |
| Anti-obesity drug use before professional treatment in Taiwan. | Asia Pacific journal of clinical nutrition 20070101 |
| [Hazard for human health and life by unintentional use of synthetic sibutramine, which was sold as Chinese herbal product 'meizitanc']. | Przeglad lekarski 20070101 |
| [Side effects after the usage of Chinese dieting product Meizitanc]. | Przeglad lekarski 20070101 |
| Anorexic effect of (R)-sibutramine: comparison with (RS)-sibutramine [corrected] and (S)-sibutramine. | Indian journal of physiology and pharmacology 20070101 |
| Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients. | Chang Gung medical journal 20070101 |
| Comparison of lipid lowering effect of sibutramine in patients treated or not treated with statins--3 month follow-up. | Prague medical report 20070101 |
| Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. | The European journal of health economics : HEPAC : health economics in prevention and care 20061201 |
| Sibutramine for obesity in adolescents. | Expert opinion on pharmacotherapy 20061201 |
| Metabolic syndrome treatment strategies. | Pharmacotherapy 20061201 |
| The sibutramine metabolite M2 improves muscle glucose uptake and reduces hepatic glucose output: preliminary data. | Diabetes & vascular disease research 20061201 |
| [Pharmacotherapy of obesity]. | Medizinische Monatsschrift fur Pharmazeuten 20061201 |
| Tolerability and effectiveness of fluoxetine, metformin and sibutramine in reducing anthropometric and metabolic parameters in obese patients. | Arquivos brasileiros de endocrinologia e metabologia 20061201 |
| Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance. | Eating and weight disorders : EWD 20061201 |
| Locomotor and peripheral effects of sibutramine modulated by 5-HT2 receptors. | Canadian journal of physiology and pharmacology 20061201 |
| Reduced left ventricular mass after treatment of obese patients with sibutramine: An echocardiographic multicentre study. | Diabetes, obesity & metabolism 20061101 |
| Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme. | The British journal of nutrition 20061101 |
| The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20061101 |
| Serotonin and norepinephrine reuptake inhibition and eating behavior. | Annals of the New York Academy of Sciences 20061101 |
| Current and novel approaches to the drug therapy of obesity. | European journal of clinical pharmacology 20061001 |
| Identification of a sibutramine-metabolite in patient urine after intake of a 'pure herbal' Chinese slimming product. | Therapeutic drug monitoring 20061001 |
| Pharmacotherapy of obesity. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20061001 |
| Anorectic sibutramine detected in a Chinese herbal drug for weight loss. | Forensic science international 20060912 |
| Metabolite profile of sibutramine in human urine: a liquid chromatography-electrospray ionization mass spectrometric study. | Journal of mass spectrometry : JMS 20060901 |
| Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand. | International journal of obesity (2005) 20060801 |
| Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. | British journal of pharmacology 20060801 |
| Norepinephrine transporter inhibition prevents tilt-induced pre-syncope. | Journal of the American College of Cardiology 20060801 |
| Weight loss medications--where do they fit in? | Australian family physician 20060801 |
| Pharmacologic treatment for obesity. Options for today...and tomorrow. | Advance for nurse practitioners 20060801 |
| Peripheral mechanisms of sibutramine involving proximal gastric motility in dogs. | Obesity (Silver Spring, Md.) 20060801 |
| Summaries for patients. Effects of drug treatment for obesity in adolescence. | Annals of internal medicine 20060718 |
| Effects of sibutramine treatment in obese adolescents: a randomized trial. | Annals of internal medicine 20060718 |
| What constitutes successful weight management in adolescents? | Annals of internal medicine 20060718 |
| The obesity epidemic and its cardiovascular consequences. | Current opinion in cardiology 20060701 |
| Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease. | The American journal of cardiology 20060601 |
| Use of lifestyle changes treatment plans and drug therapy in controlling cardiovascular and metabolic risk factors. | Obesity (Silver Spring, Md.) 20060601 |
| Influence of weight reduction by sibutramine on female sexual function. | International journal of obesity (2005) 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder. | Diabetes, obesity & metabolism 20060501 |
| Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects. | Clinical pharmacology and therapeutics 20060501 |
| Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. | Clinical therapeutics 20060501 |
| QT interval prolongation associated with sibutramine treatment. | British journal of clinical pharmacology 20060401 |
| Locomotion is the major determinant of sibutramine-induced increase in energy expenditure. | Pharmacology, biochemistry, and behavior 20060401 |
| Keeping weight-loss drugs in perspective. If you're dangerously overweight, diet pills may help--but not without major lifestyle changes. | Harvard women's health watch 20060401 |
| Pharmacological treatment of obesity. | Arquivos brasileiros de endocrinologia e metabologia 20060401 |
| Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice. | Endocrine 20060401 |
| [Pharmacotherapy in the treatment of obesity]. | MMW Fortschritte der Medizin 20060302 |
| Neurochemical, neuroautonomic and neuropharmacological acute effects of sibutramine in healthy subjects. | Neurotoxicology 20060301 |
| Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients. | Diabetes, obesity & metabolism 20060301 |
| Clinical trial issues in weight-loss therapy. | American heart journal 20060301 |
| Weight loss as a treatment for nonalcoholic fatty liver disease. | Journal of clinical gastroenterology 20060301 |
| Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates. | Physiology & behavior 20060227 |
| Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive rats. | Peptides 20060201 |
| Central nervous system biogenic amine targets for control of appetite and energy expenditure. | Endocrine 20060201 |
| [Spectroscopic studies on the binding of sibutramine hydrochloride and bovine serum albumin]. | Yao xue xue bao = Acta pharmaceutica Sinica 20060201 |
| [Drug treatment of obesity]. | Ugeskrift for laeger 20060109 |
| Pharmacotherapy for obesity. | Appetite 20060101 |
| Pharmacologic treatment of obesity. | Advances in psychosomatic medicine 20060101 |
| Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity. | The Israel Medical Association journal : IMAJ 20060101 |
| [Reducing obesity]. | Presse medicale (Paris, France : 1983) 20060101 |
| Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. | Drug safety 20060101 |
| Assessment and management of the obese adult female: a clinical update for providers. | Journal of midwifery & women's health 20060101 |
| Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry. | European journal of mass spectrometry (Chichester, England) 20060101 |
| Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. | The Annals of pharmacotherapy 20060101 |
| Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk. | Asia Pacific journal of clinical nutrition 20060101 |
| Valuable lessons from research on drugs for adolescent obesity in Mexico. | Advances in therapy 20060101 |
| Liquid chromatography/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence study. | Rapid communications in mass spectrometry : RCM 20060101 |
| Medical management of obesity. | Acta clinica Belgica 20060101 |
| Effects of sibutramine on thermogenesis in obese patients assessed via immersion calorimetry. | Advances in therapy 20060101 |
| Obesity. | Annual review of clinical psychology 20060101 |
| Sibutramine therapy in obese women--effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations. | Neuro endocrinology letters 20051201 |
| Serotonin syndrome and the anaesthetist. | Anaesthesia and intensive care 20051201 |
| Randomized trial of lifestyle modification and pharmacotherapy for obesity. | The New England journal of medicine 20051117 |
| Pharmacotherapy for obesity--promise and uncertainty. | The New England journal of medicine 20051117 |
| Sibutramine use associated with reversible hepatotoxicity. | Annals of internal medicine 20051115 |
| Rapid treatment of posttraumatic stress disorder with sibutramine. | Epilepsy & behavior : E&B 20051101 |
| Pharmacologic agents for the treatment of obesity. | Clinics in geriatric medicine 20051101 |
| Trends in obesity and overweight-related office visits and drug prescriptions in Canada, 1998 to 2004. | Obesity research 20051101 |
| Sibutramine in pregnancy. | European journal of obstetrics, gynecology, and reproductive biology 20051001 |
| Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study. | Journal of human hypertension 20050901 |
| Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study. | Sleep medicine 20050901 |
| New options for drug treatment of obesity in patients with Type 2 diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20050901 |
| Childhood obesity. Treatment options. | Best practice & research. Clinical endocrinology & metabolism 20050901 |
| [Effects of sibutramine on blood glucose and lipids, body fat mass and insulin resistance in obese patients: a multi-center clinical trial]. | Zhonghua nei ke za zhi 20050901 |
| New drug policy in childhood obesity. | International journal of obesity (2005) 20050901 |
| Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20050801 |
| Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study. | European journal of clinical nutrition 20050801 |
| Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study. | International journal of clinical practice 20050701 |
| Control of diastereoselectivity by solvent effects in the addition of Grignard reagents to enantiopure t-butylsulfinimine: syntheses of the stereoisomers of the hydroxyl derivatives of sibutramine. | Organic letters 20050623 |
| Two-year outcome of a combination of weight loss therapies for type 2 diabetes. | Diabetes care 20050601 |
| Sibutramine and the sympathetic nervous system in obese humans. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20050601 |
| Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20050601 |
| Obesity. | Clinical evidence 20050601 |
| Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials. | International journal of obesity (2005) 20050501 |
| Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients. | Diabetes, obesity & metabolism 20050501 |
| A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. | The American journal of psychiatry 20050501 |
| Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats. | European journal of pharmacology 20050425 |
| Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies. | Diabetes care 20050401 |
| Pharmacological treatments for obesity. | Professional nurse (London, England) 20050401 |
| Obesity and cardiovascular physiology: impact of some pharmacological agents. | Current vascular pharmacology 20050401 |
| [Obesity pharmacological treatment]. | Revista clinica espanola 20050401 |
| [Evaluation of the sibutramine effect on satiety with a visual analogue scale in obese adolescents]. | Arquivos brasileiros de endocrinologia e metabologia 20050401 |
| Sibutramine: possible cause of a reversible cardiomyopathy. | International journal of cardiology 20050330 |
| Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents. | European journal of pharmacology 20050321 |
| Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. | The Journal of clinical endocrinology and metabolism 20050301 |
| Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. | Current drug targets 20050301 |
| The stereoselective biotransformation of the anti-obesity drug sibutramine in rat liver microsomes and in primary cultures of rat hepatocytes. | The Journal of pharmacy and pharmacology 20050301 |
| A review of the metabolic effects of sibutramine. | Current medical research and opinion 20050301 |
| Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper. | Methods and findings in experimental and clinical pharmacology 20050301 |
| Safety pharmacology of sibutramine mesylate, an anti-obesity drug. | Human & experimental toxicology 20050301 |
| [Obesity and metabolic syndrome: clinical and therapeutic review]. | Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20050301 |
| Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine. | International journal of obesity (2005) 20050201 |
| Sibutramine treatment in obesity: initial eating behaviour in relation to weight loss results and changes in mood. | Pharmacological research 20050201 |
| Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20050201 |
| Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. | The Cochrane database of systematic reviews 20050125 |
| Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients. | Diabetes, obesity & metabolism 20050101 |
| Does prior authorization of sibutramine improve medication compliance or weight loss? | Obesity research 20050101 |
| Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. | Advances in therapy 20050101 |
| Cost-effectiveness of sibutramine in the LOSE Weight Study: evaluating the role of pharmacologic weight-loss therapy within a weight management program. | Journal of managed care pharmacy : JMCP 20050101 |
| Effect of sibutramine on blood pressure in patients with obesity and well-controlled hypertension or normotension. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101 |
| Pharmacotherapy to reduce visceral fat. | Clinical cornerstone 20050101 |
| Use of sibutramine in obese Hispanic adolescents. | Advances in therapy 20050101 |
| [The 'problem obesity': viewpoint of the internist]. | Annali italiani di chirurgia 20050101 |
| Diets, drugs, exercise, and behavioral modification: Where these work and where they do not. | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20050101 |
| Sibutramine may be associated with memory impairment. | BMJ (Clinical research ed.) 20041204 |
| Modern, new pharmacotherapy for obesity. A gastrointestinal approach. | Best practice & research. Clinical gastroenterology 20041201 |
| Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women. | Diabetes research and clinical practice 20041201 |
| Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20041201 |
| Medical management of obesity in women: office-based approaches to weight management. | Clinical obstetrics and gynecology 20041201 |
| Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects. | Acta diabetologica 20041201 |
| Long-term pharmacotherapy for obesity. | Obesity research 20041201 |
| Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study. | Clinical therapeutics 20041201 |
| A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20041112 |
| Effects of sibutramine on anxiety-related behaviours in rats. | Pharmacological research 20041101 |
| Combined dietary and pharmacological weight management in obese hypopituitary patients. | Obesity research 20041101 |
| [Sibutramin in obesity treatment (multicenter, open, prospective 12-month-long study)]. | Vnitrni lekarstvi 20041101 |
| [Pharmacotherapy of obesity]. | Ugeskrift for laeger 20041018 |
| Clinical pharmacotherapy for obesity: current drugs and those in advanced development. | Current drug targets 20041001 |
| Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry. | Obesity research 20041001 |
| A perspective on the current strategies for the treatment of obesity. | Current drug targets. CNS and neurological disorders 20041001 |
| Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20041001 |
| Exposure to sibutramine during pregnancy: a case series. | European journal of obstetrics, gynecology, and reproductive biology 20040910 |
| Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial. | Clinical therapeutics 20040901 |
| [A multicenter and open study on efficacy and safety of sibutramine in obese subjects]. | Zhonghua yi xue za zhi 20040802 |
| Sibutramine use in pregnancy: report of two cases. | Birth defects research. Part A, Clinical and molecular teratology 20040801 |
| The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats. | Obesity research 20040801 |
| Comparison of the acute pharmacodynamic responses after single doses of ephedrine or sibutramine in healthy, overweight volunteers. | International journal of clinical pharmacology and therapeutics 20040801 |
| Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients. | Diabetes, nutrition & metabolism 20040801 |
| Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. | Archives of internal medicine 20040712 |
| [Pharmacotherapy of obesity]. | Wiener medizinische Wochenschrift (1946) 20040701 |
| Pharmacological and surgical treatment of obesity. | Evidence report/technology assessment (Summary) 20040701 |
| The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization. | The American journal of managed care 20040601 |
| Prediction of successful weight reduction under sibutramine therapy. | Pharmacogenetics 20040601 |
| [Binge eating disorder: an emerging entity that responds to pharmacotherapy]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040601 |
| [Sibutramine administration in polycystic ovary syndrome treatment]. | Ginekologia polska 20040601 |
| Croatian experience with sibutramine in the treatment of obesity--multicenter prospective study. | Collegium antropologicum 20040601 |
| Obesity. | Clinical evidence 20040601 |
| The efficacy and safety of sibutramine for weight loss: a systematic review. | Archives of internal medicine 20040510 |
| Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. | Health technology assessment (Winchester, England) 20040501 |
| Comparison of efficacy of sibutramine or orlistat versus their combination in obese women. | Endocrine research 20040501 |
| [Sustained weight reduction after cessation of obesity treatment with Sibutramine]. | Deutsche medizinische Wochenschrift (1946) 20040430 |
| Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20040401 |
| Food intake with an antiobesity drug (sibutramine) versus placebo and rorschach data: a crossover within-subjects study. | Journal of personality assessment 20040401 |
| Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. | Metabolism: clinical and experimental 20040401 |
| Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20040401 |
| The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects. | Diabetes, nutrition & metabolism 20040401 |
| Acute cardiovascular effects of sibutramine in conscious rats. | The Journal of pharmacology and experimental therapeutics 20040301 |
| Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20040301 |
| 5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354. | Neuropharmacology 20040301 |
| Sibutramine and the management of obesity. | Expert opinion on pharmacotherapy 20040301 |
| Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients? | The Tohoku journal of experimental medicine 20040301 |
| [Studies of the effects of sibutramine hydrochloride on perinatal development and maternal function in mice]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20040301 |
| Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine. | European journal of pharmacology 20040126 |
| [Struggle about the best reducing diet, Fat gone by means of more fat?]. | MMW Fortschritte der Medizin 20040115 |
| Effects of the sibutramine therapy on pulmonary artery pressure in obese patients. | Diabetes, obesity & metabolism 20040101 |
| Obesity management in patients with type 2 diabetes mellitus. | Mymensingh medical journal : MMJ 20040101 |
| What role for weight-loss medication? Weighing the pros and cons for obese patients. | Postgraduate medicine 20040101 |
| Clinical use of sibutramine. | Drugs of today (Barcelona, Spain : 1998) 20040101 |
| Cost-effectiveness of sibutramine in the treatment of obesity. | Medical decision making : an international journal of the Society for Medical Decision Making 20040101 |
| [Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia]. | Przeglad lekarski 20040101 |
| Long-term pharmacotherapy for obesity and overweight. | The Cochrane database of systematic reviews 20040101 |
| [Pharmacological treatment of obesity]. | Revista de medicina de la Universidad de Navarra 20040101 |
| Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women. | Bratislavske lekarske listy 20040101 |
| [Pharmacological treatment for obesity]. | Gaceta medica de Mexico 20040101 |
| Managing type 2 diabetes mellitus in patients with obesity. | Treatments in endocrinology 20040101 |
| Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20031201 |
| Great expectations: 'I'm losing 25% of my weight no matter what you say'. | Journal of consulting and clinical psychology 20031201 |
| Obesity and pharmacologic therapy. | Endocrinology and metabolism clinics of North America 20031201 |
| Obesity. | Clinical evidence 20031201 |
| [Serum leptin and insulin resistance in obesity and effects of sibutramine on them]. | Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University 20031201 |
| [Effectiveness of therapeutic interventions in obesity]. | Praxis 20031119 |
| Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. | Fertility and sterility 20031101 |
| A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. | Archives of general psychiatry 20031101 |
| Sibutramine treatment in obesity: predictors of weight loss including rorschach personality data. | Obesity research 20031101 |
| Effect of sibutramine on macronutrient selection in male and female rats. | Physiology & behavior 20031101 |
| Pharmacokinetics of sibutramine hydrochloride in Chinese healthy volunteers. | Yao xue xue bao = Acta pharmaceutica Sinica 20031101 |
| [New therapeutic options in obesity]. | MMW Fortschritte der Medizin 20031016 |
| The implementation of nutritional advice for people with diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20031001 |
| Advances in eating disorders offer food for thought. | JAMA 20030917 |
| Management of the overweight patient with Type 2 diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20030901 |
| Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial. | Diabetes, obesity & metabolism 20030901 |
| Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. | Obesity research 20030901 |
| The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis. | Romanian journal of gastroenterology 20030901 |
| Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. | Pharmacogenetics 20030801 |
| Sibutramine in the management of obesity. | The Journal of family practice 20030801 |
| Sibutramine sensitivity assay revealed a unique phenotype of bombesin BB3 receptor-deficient mice. | European journal of pharmacology 20030718 |
| [What effect does losing weight have on hypertension?]. | MMW Fortschritte der Medizin 20030710 |
| Interaction between sibutramine and cyclosporine. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030701 |
| Severe bullous drug eruption due to sibutramine (Reductil). | The British journal of dermatology 20030701 |
| Postmarketing surveillance for drug abuse. | Drug and alcohol dependence 20030605 |
| Pharmacological therapy of obesity: past, present, and future. | The Journal of clinical endocrinology and metabolism 20030601 |
| Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20030601 |
| Health risks, past usage, and intention to use weight loss products in normal weight women with high and low body dysphoria. | Eating and weight disorders : EWD 20030601 |
| Use of sibutramine to treat obesity. | Primary care 20030601 |
| Potential for sibutramine-yohimbine interaction? | Lancet (London, England) 20030524 |
| [A drug help in reducing? Risk profile decides whether and how]. | MMW Fortschritte der Medizin 20030522 |
| [Abuse potential of sibutramine]. | Medicina clinica 20030503 |
| Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm. | Obesity research 20030501 |
| Experimental drugs take aim at obesity. | JAMA 20030409 |
| Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. | JAMA 20030409 |
| Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. | Psychopharmacology 20030401 |
| Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins. | Nutritional neuroscience 20030401 |
| Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat. | Pharmacology, biochemistry, and behavior 20030401 |
| [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?]. | MMW Fortschritte der Medizin 20030306 |
| Determination of the active metabolite of sibutramine by liquid chromatography-electrospray ionization tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030305 |
| Postmarketing surveillance of abuse liability of sibutramine. | Drug and alcohol dependence 20030301 |
| Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women. | Obesity research 20030301 |
| Ask the doctor. I took the diet drug sibutramine (Meridia) for two months but stopped when I heard that its use had been linked to some deaths. During this time I developed mitral valve regurgitation. Could this have been a side effect of Meridia? | Harvard heart letter : from Harvard Medical School 20030301 |
| [Weight loss via drug therapy]. | Der Internist 20030301 |
| Obesity drug pipeline not so fat. | Science (New York, N.Y.) 20030207 |
| Medical management of obesity: a clinical imperative? | Current diabetes reports 20030201 |
| A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. | Diabetes care 20030101 |
| Bombesin receptor subtype-3 modulates plasma insulin concentration. | Peptides 20030101 |
| Obesity. | Clinical medicine (London, England) 20030101 |
| Weight management and current options in pharmacotherapy: orlistat and sibutramine. | Clinical therapeutics 20030101 |
| Medical management of obesity: present and future therapy. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20030101 |
| Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension. | Advances in therapy 20030101 |
| A benefit-risk assessment of sibutramine in the management of obesity. | Drug safety 20030101 |
| Long-term pharmacotherapy for obesity and overweight. | The Cochrane database of systematic reviews 20030101 |
| Sibutramine: its mode of action and efficacy. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20021201 |
| Metabolic benefits associated with sibutramine therapy. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20021201 |
| Sibutramine and its cardiovascular profile. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20021201 |
| Pharmacotherapy of obesity. | Best practice & research. Clinical endocrinology & metabolism 20021201 |
| Pharmacological management of obesity. | Expert opinion on pharmacotherapy 20021201 |
| New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. | Diabetes & metabolism 20021201 |
| First application of tunable alkyl or aryl sulfinamides to the stereoselective synthesis of a chiral amine: asymmetric synthesis of (R)-didesmethylsibutramine ((R)-DDMS) using (R)-triethylmethylsulfinamide ((R)-TESA). | Organic letters 20021114 |
| Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. | Organic letters 20021114 |
| Paradoxical effect of sibutramine on autonomic cardiovascular regulation. | Circulation 20021105 |
| The new role of pharmacotherapy for weight reduction in obesity. | International journal of clinical practice 20021101 |
| New pharmacological tools for obesity. | Journal of endocrinological investigation 20021101 |
| Add-on combination and maintenance treatment: case series of five obese patients with different eating behavior. | Journal of clinical psychopharmacology 20021001 |
| Sibutramine and panic attacks. | The American journal of psychiatry 20021001 |
| Sibutramine for compulsive eating in hypothalamic deficiency. | Journal of the American Academy of Child and Adolescent Psychiatry 20021001 |
| Major depressive episodes and diet pills. | Expert opinion on pharmacotherapy 20021001 |
| Effectiveness of sibutramine. | The Journal of family practice 20021001 |
| Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors. | European journal of pharmacology 20020927 |
| [Cardiac safety and sibutramine]. | Medicina clinica 20020921 |
| [Weight loss lowers blood pressure, lipids and blood glucose. Sibutramine also helps diabetics with weight loss]. | MMW Fortschritte der Medizin 20020912 |
| Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20020901 |
| Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction. | American heart journal 20020901 |
| Treatment of fibromyalgia with sibutramine hydrochloride monohydrate: comment on the article by Goldenberg et al. | Arthritis and rheumatism 20020901 |
| Sibutramine-induced mania episode in a bipolar patient. | The international journal of neuropsychopharmacology 20020901 |
| Sibutramine lost and found. | Eating and weight disorders : EWD 20020901 |
| Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. | Diabetes 20020801 |
| Drugs under investigation for attention-deficit hyperactivity disorder. | Current opinion in investigational drugs (London, England : 2000) 20020801 |
| [The anti-obesity drug sibutramine for overweight diabetic patients. 'Blood pressure is not elevated')]. | MMW Fortschritte der Medizin 20020711 |
| Options for pharmacological management of obesity in patients treated with atypical antipsychotics. | International clinical psychopharmacology 20020701 |
| Combining behavioral and pharmacological treatments for obesity. | Obesity research 20020601 |
| Sibutramine warning: hypertension and cardiac arrhythmias reported. | Obesity surgery 20020601 |
| Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020514 |
| [Extra pounds despite sports and diets. Genetics can also be involved]. | MMW Fortschritte der Medizin 20020509 |
| I have tried everything I can think of to lose weight on my own and am now thinking of using weight-loss medications. Are they safe? | Heart advisor 20020501 |
| The discovery and status of sibutramine as an anti-obesity drug. | European journal of pharmacology 20020412 |
| The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity. | The Journal of clinical endocrinology and metabolism 20020401 |
| [Anti-obesity drugs: sibutramine and orlistat]. | Medicina clinica 20020330 |
| [Treatment of obesity in practice - more necessary than ever]. | Deutsche medizinische Wochenschrift (1946) 20020322 |
| [Sibutramine in clinical practice - a PMS-study with positive effects on blood pressure and metabolic parameters]. | Deutsche medizinische Wochenschrift (1946) 20020322 |
| Regulation of body weight and carcass composition by sibutramine in rats. | Obesity research 20020301 |
| Sibutramine-dependent brown fat activation in rats: an immunohistochemical study. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20020301 |
| Can drugs help you lose weight? | Harvard heart letter : from Harvard Medical School 20020301 |
| Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20020201 |
| Organic hypomania secondary to sibutramine-citalopram interaction. | The Journal of clinical psychiatry 20020201 |
| Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy. | Diabetic medicine : a journal of the British Diabetic Association 20020201 |
| Effects of sibutramine on the treatment of obesity in patients with arterial hypertension. | Arquivos brasileiros de cardiologia 20020201 |
| Effects of sibutramine in non-dieting obese women. | Journal of endocrinological investigation 20020201 |
| [Study of heart valve function on obese patients treated with sibutramine]. | Medicina clinica 20020126 |
| Risk factor modification through weight loss enhanced with pharmacotherapy. | Current atherosclerosis reports 20020101 |
| Measuring the effect of sibutramine for weight loss. | JAMA 20020101 |
| An open-label trial of sibutramine in obese patients with binge-eating disorder. | The Journal of clinical psychiatry 20020101 |
| Sibutramine and blood pressure: a therapeutic dilemma. | Journal of human hypertension 20020101 |
| Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. | Journal of human hypertension 20020101 |
| Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. | Journal of human hypertension 20020101 |
| Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. | Diabetes, obesity & metabolism 20020101 |
| The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment. | Health technology assessment (Winchester, England) 20020101 |
| [Weight reduction. Antiobesity drug treatment in type-2 diabetics]. | Pharmazie in unserer Zeit 20020101 |
| Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study. | Revista do Hospital das Clinicas 20020101 |
| Pharmacologic agents for weight reduction. | The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 20020101 |
| Obesity, cardiovascular risk and pharmacotherapy. | Blood pressure 20020101 |
| [Obesity: gradual-schedule therapy and long-term results]. | MMW Fortschritte der Medizin 20011213 |
| American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. | Medicine and science in sports and exercise 20011201 |
| Does long-term use of sibutramine (Meridia) result in continued weight loss in short-term responders? | The Journal of family practice 20011201 |
| Is sibutramine more than a slim hope? | Drug and therapeutics bulletin 20011201 |
| Sibutramine in clinical practice. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011201 |
| When, for whom and how to use sibutramine? | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011201 |
| Sibutramine in overweight/obese hypertensive patients. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011201 |
| The importance of obesity in diabetes and its treatment with sibutramine. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011201 |
| The role of sibutramine in weight management--towards a blueprint for a sibutramine weight management system. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011201 |
| How does sibutramine work? | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011201 |
| [Drugs for obesity. Why are obese patients diferent?]. | Medicina clinica 20011103 |
| Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. | Diabetes care 20011101 |
| Current methods used for defining, measuring, and treating obesity. | Seminars in urologic oncology 20011101 |
| Long-term medication use and weight loss maintenance: an observational study. | Obesity research 20011001 |
| Long-term weight loss with sibutramine: a randomized controlled trial. | JAMA 20010919 |
| Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia. | American heart journal 20010901 |
| Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo. | The American journal of managed care 20010901 |
| Weight loss and health-related quality of life. | The American journal of managed care 20010901 |
| [Pharma-clinics. Medication of the month. Sibutramine (Reductil)]. | Revue medicale de Liege 20010901 |
| Obesity: a new paradigm in endocrinology. | Eating and weight disorders : EWD 20010901 |
| The advances on the knowledge base of obesity and future therapeutic directions. | Eating and weight disorders : EWD 20010901 |
| [A randomized, double-blind, placebo-controlled, multicenter study on sibutramine in over-weighted and obese subjects]. | Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 20010901 |
| Clinical evaluation of sibutramine in obese type 2 diabetic patients refractory to dietary management. | The Journal of the Association of Physicians of India 20010901 |
| Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. | Metabolism: clinical and experimental 20010801 |
| Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet--exercise intervention. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010801 |
| Insulin-leptin-visceral fat relation during weight loss. | Pancreas 20010801 |
| Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. | Archives of internal medicine 20010801 |
| Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. | Metabolism: clinical and experimental 20010701 |
| Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. | Metabolism: clinical and experimental 20010701 |
| Drug treatment for obesity. We need more studies in men at higher risk of coronary events. | BMJ (Clinical research ed.) 20010609 |
| Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. | The Journal of family practice 20010601 |
| Treating obesity in the family practice setting. | Postgraduate medicine 20010601 |
| Achieving weight-loss maintenance. | Postgraduate medicine 20010601 |
| Exploring synergies in the treatment of obesity. | Postgraduate medicine 20010601 |
| Emerging strategies for weight management. Summary. | Postgraduate medicine 20010601 |
| [The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial]. | Ugeskrift for laeger 20010521 |
| Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010501 |
| Current pharmacological approaches to the treatment of obesity. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010501 |
| Drug therapy for management of obesity. | Lancet (London, England) 20010421 |
| [Weight reduction. Doubly effective with drug support]. | MMW Fortschritte der Medizin 20010412 |
| [Observational study. Sibutramine in general practice]. | MMW Fortschritte der Medizin 20010412 |
| [Sibutramine--antidepressive agent tested against obesity]. | Lakartidningen 20010411 |
| Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y. | British journal of pharmacology 20010401 |
| Sibutramine metabolites increase glucose transport by cultured rat muscle cells. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010401 |
| Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010401 |
| Influence of sibutramine on energy expenditure in African American women. | Obesity research 20010401 |
| Toward optimal health: the experts discuss weight control drugs. Interview by Jodi Godfrey Meisler. | Journal of women's health & gender-based medicine 20010301 |
| Diet drug helps keep weight off. | Health news (Waltham, Mass.) 20010201 |
| Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. | Archives of internal medicine 20010122 |
| Serotonin syndrome: potential consequences of Meridia combined with Demerol or fentanyl. | Plastic and reconstructive surgery 20010101 |
| [Clinical study of the month. After the storm over central anorectic agents, the 'STORM' study of sibutramine]. | Revue medicale de Liege 20010101 |
| Treating obesity: a new target for prevention of coronary heart disease. | Progress in cardiovascular nursing 20010101 |
| Epidemiology, morbidity, and treatment of overweight and obesity. | The Journal of clinical psychiatry 20010101 |
| Weight loss can be as simple as 10, 20, 30--Knoll launches blueprint for the use of sibutramine in weight management. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101 |
| An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20001001 |
| [Obesity: principles of drug therapy]. | Therapeutische Umschau. Revue therapeutique 20000801 |
| Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. | The Annals of pharmacotherapy 19990901 |
| Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 19980801 |
| Sibutramine: a review of the pharmacology of a novel anti-obesity agent. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 19970301 |